PMC:7558914 / 23671-25333 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T151 0-173 Sentence denotes As recent studies have found, severe COVID-19 is commonly complicated with coagulopathy, including disseminated intravascular coagulation and venous thromboembolism [33,34].
T152 174-348 Sentence denotes For this reason, the administration of heparin has been recommended for COVID-19 patients according to expert consensus [4,31], although its efficacy remains to be validated.
T153 349-634 Sentence denotes In a study of 449 patients with severe COVID-19 and sepsis-induced coagulopathy criteria or with markedly elevated D-dimer levels (higher than sixfold of upper limit of normal), anticoagulant therapy, mainly with low-molecular-weight heparin, was associated with better prognosis [34].
T154 635-767 Sentence denotes Beyond severe coagulopathy, special attention to venous thromboembolism prophylaxis is necessary in the management of COVID-19 [35].
T155 768-946 Sentence denotes Low-molecular-weight heparin is preferred over unfractionated heparin in order to reduce patient contact (depending on the patient’s bleeding risk and creatinine clearance) [36].
T156 947-1072 Sentence denotes We found that all protocols analyzed included anticoagulant treatment, with low-molecular-weight heparin as the first option.
T157 1073-1161 Sentence denotes It was recommended that all hospitalized COVID-19 patients receive prophylactic heparin.
T158 1162-1288 Sentence denotes This recommendation was extended to after discharge if necessitated by the patient’s clinical condition in 46.6% of protocols.
T159 1289-1413 Sentence denotes An increase in prophylactic heparin doses was recommended in 53.3% of the protocols for patients at high risk of thrombosis.
T160 1414-1571 Sentence denotes In five protocols (33.3%), heparin was increased to therapeutic doses if the condition was critical or if there was a progressive increase in D-dimer levels.
T161 1572-1662 Sentence denotes All protocol included therapeutic heparin if there was evidence of venous thromboembolism.